John E. Edwards
Fondateur chez NovaDigm Therapeutics, Inc.
Postes actifs de John E. Edwards
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| University of California, Los Angeles | Corporate Officer/Principal | - | - |
NovaDigm Therapeutics, Inc.
 NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND. | Fondateur | 01/01/2005 | - |
Historique de carrière de John E. Edwards
Anciens postes connus de John E. Edwards
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
NIH Research, Inc.
 NIH Research, Inc. Miscellaneous Commercial ServicesCommercial Services NIH Research, Inc. provided healthcare consulting services. The company was headquartered in Coral Springs, FL. | Corporate Officer/Principal | - | - |
Formation de John E. Edwards
| Pomona College | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Commercial Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
NIH Research, Inc.
NIH Research, Inc. Miscellaneous Commercial ServicesCommercial Services NIH Research, Inc. provided healthcare consulting services. The company was headquartered in Coral Springs, FL. | Commercial Services |
NovaDigm Therapeutics, Inc.
NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND. | Health Technology |
- Bourse
- Insiders
- John E. Edwards
- Expérience
